This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Impaired Glucose Tolerance
and you are
between 18 and 55
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The study will evaluate the effects of resveratrol/leucine and resveratrol/HMB for their ability to control glucose levels in persons without diabetes but with impaired fasting glucose. Secondary assessments will examine the effect of these nutritional supplements versus placebo on inflammation, fasting lipids, HbA1C, and fructosamine, longer term metabolic markers of risk in diabetes.

Provided treatments

  • : Resveratrol
  • : resveratrol /HMB
  • Other: Placebo treatment

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01593605. The sponsor of the trial is Vanderbilt University and it is looking for 36 volunteers for the current phase.
Official trial title:
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes